Winslow Evans & Crocker’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
Winslow Evans & Crocker's BLUE Position: Q4 2020 in Review
Winslow Evans & Crocker increased its bluebird bio (BLUE) stake by 39% in Q4 2020, buying an estimated $41.8K and bringing the position to 236 shares worth $133K. The position accounts for 0.03% of the portfolio, ranked #392.
Winslow Evans & Crocker first reported a position in BLUE in Q3 2015 and has held it in 22 quarters since. The position peaked at $630K in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.
- Winslow Evans & Crocker held 236 shares of bluebird bio worth $133K as of Q4 2020.
- Winslow Evans & Crocker bought 66 bluebird bio shares in Q4 2020, an estimated $41.8K.
- bluebird bio made up 0.03% of Winslow Evans & Crocker's portfolio in Q4 2020, its #392 holding.
- Winslow Evans & Crocker first reported a position in bluebird bio in Q3 2015 and has held it in 22 quarters since.
- Winslow Evans & Crocker's bluebird bio position peaked at $630K in Q1 2019.
- 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.
Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.